The global hormone replacement therapy (HRT) market is expected
to expand due to the rising prevalence of hormonal disorders and
the availability of advanced delivery systems.
WILMINGTON, Del., July 11, 2024 /PRNewswire/ -- The global
hormone replacement therapy market stood at US$ 21 billion in 2023, and the global market
is projected to reach US$ 38.8
billion in 2034. The hormone replacement therapy
market is anticipated to expand at a CAGR of 5.7% between
2024 and 2034.
The hormone replacement therapy (HRT) market is experiencing
robust growth, driven by increasing awareness of aging-related
health issues and the quest for improved quality of life. HRT
involves the administration of hormones to alleviate symptoms
associated with menopause, andropause, and other hormonal
imbalances.
As the global population ages, the demand for HRT is surging,
particularly among women seeking relief from menopausal symptoms
such as hot flashes, night sweats, and mood swings. This therapy
not only helps in managing these symptoms but also plays a crucial
role in preventing long-term health issues like osteoporosis and
cardiovascular diseases.
Technological advancements and research in HRT have
significantly enhanced the safety and efficacy of these treatments.
Modern HRT formulations, including bioidentical hormones that mimic
the body's natural hormones, have gained popularity due to their
perceived lower risk of side effects compared to traditional
synthetic hormones.
Additionally, the development of personalized HRT regimens
tailored to individual hormonal profiles is gaining traction,
offering more precise and effective treatment options. This shift
towards personalized medicine is expected to further propel market
growth as it caters to the specific needs and preferences of
patients.
Moreover, the increasing acceptance of HRT among men is
contributing to market expansion. Men experiencing symptoms of
andropause, such as fatigue, depression, and reduced libido, are
turning to HRT for relief and improved vitality. The growing
emphasis on men's health and wellness is driving demand for
testosterone replacement therapies, thereby broadening the HRT
market.
However, the HRT market faces challenges, including concerns
about the potential risks of long-term hormone use and the need for
regular monitoring by healthcare professionals. Educating patients
and healthcare providers about the benefits and risks of HRT is
crucial for informed decision-making. Despite these challenges, the
HRT market is poised for continued growth, driven by advancements
in treatment options and a growing focus on enhancing the quality
of life for aging populations.
Request for sample PDF copy of report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=610
Hormone Replacement Therapy Market Report Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 21.0 Bn
|
Forecast (Value) in
2034
|
US$ 38.8 Bn
|
Growth Rate
(CAGR)
|
5.70 %
|
No. of
Pages
|
164
Pages
|
Segments
covered
|
By Treatment
Type,
By Route of
Administration,
By Disease
Indication,
By Distribution
Channel
|
Key Takeaways of Market Report
- Global hormone replacement therapy market to generate absolute
dollar opportunity worth US$ 38.8
billion until 2034.
- Global hormone replacement therapy market is valued at
US$ 21 billion in 2023.
- North America is forecasted to
hold the largest share in 2023.
Hormone Replacement Therapy Market: Growth
Drivers
- Menopause is widely recognized as a common gynecological
condition affecting women, marked by symptoms like hot flashes,
night sweats, mood swings, and decreased bone density. Hormone
replacement therapy (HRT) is often employed to alleviate these
symptoms and enhance overall quality of life, providing relief and
preventing long-term health issues like osteoporosis and
cardiovascular diseases.
- Growth hormone deficiency is a rare endocrine disorder in
adults, presenting with symptoms such as lipid abnormalities,
reduced energy levels, insulin resistance, and decreased physical
activity.
- This condition requires careful management and treatment with
growth hormone replacement therapy to address the metabolic and
physical impairments, improve energy levels, and enhance overall
well-being. The awareness and diagnosis of this condition are
crucial for timely intervention and effective management to improve
patients' health outcomes.
Hormone Replacement Therapy Market: Regional
Landscape
- North America led the hormone
replacement therapy (HRT) market, a trend projected to continue
during the forecast period. This dominance is attributed to the
increasing number of patients with growth hormone deficiency
disorders and menopause among individuals aged 35 and above,
driving the demand for effective HRT solutions.
- Europe also holds a
significant share of the HRT market, driven by a rising incidence
of hormonal disorders among women experiencing menopausal symptoms
and a growing geriatric population affected by hypothyroidism.
- The region's advanced healthcare infrastructure and awareness
initiatives contribute to the widespread adoption of HRT,
addressing the needs of patients and enhancing their quality of
life through effective hormonal treatments.
Unlock Growth Potential in Your Industry! Download PDF
Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=610
Hormone Replacement Therapy Market: Key Developments
- In 2023, Novartis AG launched a new bioidentical hormone
replacement therapy designed to mimic the body's natural hormones
more closely.
- In 2023, Abbott Laboratories introduced an advanced hormone
delivery system, enhancing the precision and convenience of hormone
replacement therapy.
Hormone Replacement Therapy Market: Segmentation
Treatment Type
- Human Growth Hormone (HGH) Replacement Therapy
- Thyroid Replacement Therapy
- Testosterone Replacement Therapy
- Dopamine Agonist
- Somatostatin Analogue
- Others (Parathyroid Hormone Replacement Therapy, etc.)
Route of Administration
- Oral
- Parenteral
- Transdermal
Disease Indication
- Menopause
- Hypothyroidism
- Male Hypogonadism
- Growth Hormone Deficiency
- Hypoparathyroidism
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=610<ype=S
More Trending Reports by Transparency Market Research
–
- Point-of-Care Glucose Testing Market - The global
point-of-care glucose testing market is projected to flourish at a
CAGR of 4.3% from 2022 to 2032. A valuation of US$ 5.8 billion is anticipated for the market
in 2032.
- Dental Implant Motors Market - The global dental
implant motors market is expected to grow at a CAGR of 3.5%
during the forecast period from 2021 to 2031.
- Kidney Transplant Market - The global kidney transplant
market is expected to grow at a CAGR of 3.3% from
2024 to 2034 and reach US$ 116.4
Bn by the end of 2034.
- Vendor Neutral Archive (VNA) Market - The global
vendor neutral archive (VNA) market is projected to advance at a
CAGR of 12.6% from 2023 to 2034 and reach more than
US$ 1.3 Bn by the end of
2034.
About Transparency Market Research
Transparency Market Research, a global market research
company registered at Wilmington, Delaware, United States, provides custom research and
consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights
for thousands of decision makers. Our experienced team of Analysts,
Researchers, and Consultants use proprietary data sources and
various tools & techniques to gather and analyses
information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER
DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn | Twitter |
Blog | YouTube
Logo:
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/hormone-replacement-therapy-market-size-to-be-worth-usd-38-8-billion-by-2034--with-notable-cagr-of-5-7--states-transparency-market-research-inc-302194955.html